Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On January 5, 2020, Richard Pfenniger notified the Board of Directors (the "Board") of BioCardia, Inc. (the "Company") that he was resigning from his position as a member of the Board, effective immediately. The decision by Mr. Pfenniger to resign is not the result of any disagreement with the Company on any matter related to the Company's operations, policies, or practices.

The Company and the Board would like to extend their sincere appreciation to Mr. Pfenniger for his service on the Board and wish him well in the future.

Item 7.01 Regulation FD Disclosure.

On January 11, 2021, the Company issued a press release announcing the election of Dr. Zsebo to the Board at the 2020 Annual Meeting of Stockholders and the departure of Mr. Pfenniger from the Board. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

The information furnished pursuant to this Item 7.01, including Exhibit 99.1 hereto, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that section, nor shall it be deemed to be incorporated by reference in any filing made by the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.



(d) Exhibits



Exhibit   Description
  No.

99.1        BioCardia, Inc. press release dated January 11, 2021

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses